Masimo Corp
$
138.5
-2.27 (-1.61%)
| Volume: | 524,561 | Avg Vol (1m): | 490,412 |
| Market Cap $: | 7.39 Bil | Enterprise Value $: | 6.80 Bil |
| P/E (TTM): | 39.47 | P/B: | 7.84 |
| Earnings Power Value | 35.24 |
| Net Current Asset Value | 11.9 |
| Tangible Book | 16.81 |
| Projected FCF | 47.03 |
| Median P/S Value | 65.37 |
| Graham Number | 36.44 |
| Peter Lynch Value | 80.13 |
| DCF (FCF Based) | 36.83 |
| DCF (Earnings Based) | 91.09 |
YTD (-%)
Add to portfolio
Email alerts
Stock PDF
RSS
Website
Filings
Download Excel
Batch Download
Manual of Stocks™ Web
Manual of Stocks™
Manual of Stocks™ Web
Manual of Stocks™
Financial Strength : 10/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | No Debt |
Cash-To-Debt ranked
higher than
89.27%
of
205
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
MASI:
No Debt
Ranked among companies with meaningful Cash-To-Debt only.
|
Cash-To-Debt range over the past 10 years
Min: 0.49, Med: 368.39, Max: 10000
Current: 10000
|
| Equity-to-Asset | 0.85 |
Equity-to-Asset ranked
higher than
60.20%
of
196
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
MASI:
0.85
Ranked among companies with meaningful Equity-to-Asset only.
|
Equity-to-Asset range over the past 10 years
Min: -1.01, Med: 0.74, Max: 0.85
Current: 0.85
|
| Interest Coverage | No Debt |
Interest Coverage ranked
higher than
91.24%
of
137
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 21607070, Med: 63.92, Min: 0.47
MASI:
No Debt
Ranked among companies with meaningful Interest Coverage only.
|
Interest Coverage range over the past 10 years
Min: 1096.35, Med: 10000, Max: 10000
Current: 10000
|
| Piotroski F-Score | 8 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 29.08 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.46 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC 46.66%
WACC 10.32%
| ||
Profitability & Growth : 9/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 24.01 |
Operating Margin ranked
higher than
87.56%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
MASI:
24.01
Ranked among companies with meaningful Operating Margin only.
|
Operating Margin range over the past 10 years
Min: 15.88, Med: 19.17, Max: 24.29
Current: 24.01
|
| Net Margin % | 22.49 |
Net Margin ranked
higher than
78.61%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
MASI:
22.49
Ranked among companies with meaningful Net Margin only.
|
Net Margin range over the past 10 years
Min: 10.67, Med: 14.88, Max: 43.64
Current: 22.49
|
| ROE % | 22.02 |
ROE ranked
higher than
84.85%
of
198
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
MASI:
22.02
Ranked among companies with meaningful ROE only.
|
ROE range over the past 10 years
Min: 19.43, Med: 22.9, Max: 74.46
Current: 22.02
|
| ROA % | 18.31 |
ROA ranked
higher than
88.35%
of
206
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
MASI:
18.31
Ranked among companies with meaningful ROA only.
|
ROA range over the past 10 years
Min: 14.28, Med: 16.6, Max: 43.75
Current: 18.31
|
| ROC (Joel Greenblatt) % | 84.20 |
ROC (Joel Greenblatt) ranked
higher than
89.22%
of
204
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
MASI:
84.2
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
|
ROC (Joel Greenblatt) range over the past 10 years
Min: 68.84, Med: 109.38, Max: 261.45
Current: 84.2
|
| 3-Year Total Revenue Growth Rate | 10.90 |
3-Year Revenue Growth Rate ranked
higher than
52.94%
of
170
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
MASI:
9.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
|
3-Year Revenue Growth Rate range over the past 10 years
Min: -19.3, Med: 12.15, Max: 30.3
Current: 9.3
|
| 3-Year Total EBITDA Growth Rate | 25.40 |
3-Year EBITDA Growth Rate ranked
higher than
54.84%
of
155
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 426.6, Med: 10, Min: -759
MASI:
23.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
|
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 6.45, Max: 420.3
Current: 23.7
|
| 3-Year EPS w/o NRI Growth Rate | 30.60 |
3-Year EPS w/o NRI Growth Rate ranked
higher than
55.48%
of
155
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 253, Med: 12.9, Min: -782.7
MASI:
30.6
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
|
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 7.75, Max: 79
Current: 30.6
|
» MASI's 30-Y Financials
Financials (Next Earnings Date: 2019-08-01)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NAS:MASI
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Medical Instruments & Equipment » Medical Instruments & Supplies   NAICS : 339112   SIC : 3841 |
| Compare | NYSE:HRC TSE:7747 OCSE:DEMANT NZSE:FPH XTER:AFX NYSE:WST NAS:ICUI NYSE:HAE OSTO:EKTA B NAS:NVCR MIL:AMP OSTO:GETI B SZSE:002294 LSE:CTEC NAS:MMSI NYSE:CMD NYSE:STE NYSE:GKOS ASX:ANN NAS:XRAY |
| Traded in other countries | 3M4.Germany 0JZ2.UK |
| Address | 52 Discovery, Irvine, CA, USA, 92618 |
| Masimo is an Irvine, California-based medical device business focusing on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue on a global basis, with the United States representing the largest market (68% of 2017 sales), followed by Europe, the Middle East and Africa (19%), Asia and Australia (10%), and North and South America excluding the U.S. (3%). | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 39.47 |
PE Ratio ranked
higher than
74.40%
of
125
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1012.86, Med: 31.7, Min: 0.65
MASI:
39.47
Ranked among companies with meaningful PE Ratio only.
|
PE Ratio range over the past 10 years
Min: 10.97, Med: 25.35, Max: 58.88
Current: 39.47
|
| Forward PE Ratio | 45.05 |
Forward P/E ranked
lower than
87.50%
of
40
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 80, Med: 26.32, Min: 12.3
MASI:
45.05
Ranked among companies with meaningful Forward P/E only.
| N/A |
| PE Ratio without NRI | 39.47 |
PE without NRI ranked
higher than
76.42%
of
123
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 1012.86, Med: 9999, Min: 0.65
MASI:
39.47
Ranked among companies with meaningful PE without NRI only.
|
PE without NRI range over the past 10 years
Min: 10.97, Med: 25.35, Max: 58.88
Current: 39.47
|
| Price-to-Owner-Earnings | 56.15 |
Price-to-Owner-Earnings ranked
lower than
100.00%
of
83
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 631.1, Med: 30.92, Min: 1.32
MASI:
56.15
Ranked among companies with meaningful Price-to-Owner-Earnings only.
|
Price-to-Owner-Earnings range over the past 10 years
Min: 8.94, Med: 30.94, Max: 215.95
Current: 56.15
|
| PB Ratio | 7.84 |
PB Ratio ranked
lower than
100.00%
of
193
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
MASI:
7.84
Ranked among companies with meaningful PB Ratio only.
|
PB Ratio range over the past 10 years
Min: 3.41, Med: 6.17, Max: 12.3
Current: 7.84
|
| PS Ratio | 8.82 |
PS Ratio ranked
lower than
100.00%
of
192
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
MASI:
8.82
Ranked among companies with meaningful PS Ratio only.
|
PS Ratio range over the past 10 years
Min: 2.1, Med: 4.16, Max: 8.96
Current: 8.82
|
| Price-to-Free-Cash-Flow | 41.29 |
Price-to-Free-Cash-Flow ranked
lower than
100.00%
of
74
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
MASI:
41.29
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
|
Price-to-Free-Cash-Flow range over the past 10 years
Min: 8.39, Med: 29.76, Max: 2401.82
Current: 41.29
|
| Price-to-Operating-Cash-Flow | 36.71 |
Price-to-Operating-Cash-Flow ranked
lower than
100.00%
of
94
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
MASI:
36.71
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
|
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 7.89, Med: 22.14, Max: 91.96
Current: 36.71
|
| EV-to-EBIT | 32.26 |
EV-to-EBIT ranked
lower than
63.64%
of
121
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
MASI:
32.26
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: 11.2, Med: 19.1, Max: 35.7
Current: 32.26
|
| EV-to-EBITDA | 29.32 |
EV-to-EBITDA ranked
lower than
73.19%
of
138
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
MASI:
29.32
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: 10.3, Med: 17.3, Max: 33
Current: 29.32
|
| EV-to-Revenue | 7.75 |
EV-to-Revenue ranked
lower than
100.00%
of
199
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
MASI:
7.75
Ranked among companies with meaningful EV-to-Revenue only.
|
EV-to-Revenue range over the past 10 years
Min: 2, Med: 3.95, Max: 8.4
Current: 7.75
|
| PEG Ratio | 1.89 |
PEG Ratio ranked
higher than
73.91%
of
69
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 112.54, Med: 2.7, Min: 0.05
MASI:
1.89
Ranked among companies with meaningful PEG Ratio only.
|
PEG Ratio range over the past 10 years
Min: 0.66, Med: 2.68, Max: 9.24
Current: 1.89
|
| Shiller PE Ratio | 64.28 |
Shiller PE Ratio ranked
lower than
53.70%
of
54
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 600, Med: 50.97, Min: 0.42
MASI:
64.28
Ranked among companies with meaningful Shiller PE Ratio only.
|
Shiller PE Ratio range over the past 10 years
Min: 20.24, Med: 48.35, Max: 65.47
Current: 64.28
|
| Current Ratio | 7.02 |
Current Ratio ranked
lower than
56.50%
of
200
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
MASI:
7.02
Ranked among companies with meaningful Current Ratio only.
|
Current Ratio range over the past 10 years
Min: 1.25, Med: 3.01, Max: 7.02
Current: 7.02
|
| Quick Ratio | 6.25 |
Quick Ratio ranked
lower than
55.22%
of
201
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
MASI:
6.25
Ranked among companies with meaningful Quick Ratio only.
|
Quick Ratio range over the past 10 years
Min: 0.99, Med: 2.5, Max: 6.25
Current: 6.25
|
| Days Inventory | 114.63 |
Days Inventory ranked
lower than
62.94%
of
197
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
MASI:
114.63
Ranked among companies with meaningful Days Inventory only.
|
Days Inventory range over the past 10 years
Min: 100.9, Med: 110.68, Max: 119.79
Current: 114.63
|
| Days Sales Outstanding | 49.04 |
Days Sales Outstanding ranked
higher than
52.73%
of
165
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 655.77, Med: 61.97, Min: 1
MASI:
49.04
Ranked among companies with meaningful Days Sales Outstanding only.
|
Days Sales Outstanding range over the past 10 years
Min: 40.67, Med: 47.15, Max: 54.75
Current: 49.04
|
| Days Payable | 40.91 |
Days Payable ranked
lower than
100.00%
of
151
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 713.41, Med: 54.66, Min: 2
MASI:
40.91
Ranked among companies with meaningful Days Payable only.
|
Days Payable range over the past 10 years
Min: 40.91, Med: 56.67, Max: 70.9
Current: 40.91
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| 3-Year Share Buyback Rate | -3.70 |
3-Year Share Buyback Rate ranked
higher than
82.52%
of
143
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 9.1, Med: -5, Min: -273.3
MASI:
-3.7
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
|
3-Year Share Buyback Rate range over the past 10 years
Min: -79.8, Med: -1.65, Max: 4.3
Current: -3.7
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Tangible-Book | 8.24 |
Price-to-Tangible-Book ranked
lower than
100.00%
of
167
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 3100, Med: 4.77, Min: 0.22
MASI:
8.24
Ranked among companies with meaningful Price-to-Tangible-Book only.
|
Price-to-Tangible-Book range over the past 10 years
Min: 4.11, Med: 6.62, Max: 14.94
Current: 8.24
|
| Price-to-Projected-FCF | 2.94 |
Price-to-Intrinsic-Value-Projected-FCF ranked
lower than
81.33%
of
75
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 161.65, Med: 2.41, Min: 0.16
MASI:
2.94
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
|
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.34, Med: 2.32, Max: 3.93
Current: 2.94
|
| Price-to-DCF (Earnings Based) | 1.52 |
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked
lower than
100.00%
of
23
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 94.53, Med: 2.2, Min: 1.04
MASI:
1.52
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
|
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 1.26, Med: 1.43, Max: 1.6
Current: 1.52
|
| Price-to-Median-PS-Value | 2.12 |
Price-to-Median-PS-Value ranked
lower than
100.00%
of
160
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
MASI:
2.12
Ranked among companies with meaningful Price-to-Median-PS-Value only.
|
Price-to-Median-PS-Value range over the past 10 years
Min: 0.49, Med: 1, Max: 2.14
Current: 2.12
|
| Price-to-Peter-Lynch-Fair-Value | 1.73 |
Price-to-Peter-Lynch-Fair-Value ranked
higher than
64.44%
of
45
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 111.95, Med: 2.46, Min: 0.26
MASI:
1.73
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
|
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.67, Med: 1.92, Max: 5.6
Current: 1.73
|
| Price-to-Graham-Number | 3.80 |
Price-to-Graham-Number ranked
lower than
91.49%
of
94
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 53.19, Med: 2.77, Min: 0.13
MASI:
3.8
Ranked among companies with meaningful Price-to-Graham-Number only.
|
Price-to-Graham-Number range over the past 10 years
Min: 1.8, Med: 2.9, Max: 6.58
Current: 3.8
|
| Earnings Yield (Joel Greenblatt) % | 3.09 |
Earnings Yield (Greenblatt) ranked
higher than
63.29%
of
207
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
MASI:
3.09
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: 2.8, Med: 5.2, Max: 9
Current: 3.09
|
| Forward Rate of Return (Yacktman) % | 21.83 |
Forward Rate of Return ranked
higher than
91.09%
of
101
companies
in the
Medical Instruments & Supplies
industry.
Industry Max: 28.23, Med: 8.66, Min: -123.3
MASI:
21.83
Ranked among companies with meaningful Forward Rate of Return only.
|
Forward Rate of Return range over the past 10 years
Min: -30.4, Med: 8.7, Max: 22.5
Current: 21.83
|
More Statistics
| Revenue (TTM) (Mil) $ | 877 |
| EPS (TTM) $ | 3.51 |
| Beta | 1.32 |
| Volatility % | 29.01 |
| 52-Week Range $ | 95.85 - 147.91 |
| Shares Outstanding (Mil) | 53.09 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 8 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | Y |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | Y |
| Higher Asset Turnover yoy | Y |